BerGenBio ASA (LON: 0RU5)
London
· Delayed Price · Currency is GBP · Price in NOK 8.50
-0.21 (-2.46%)
Jan 17, 2025, 10:06 AM BST
BerGenBio ASA Market Cap
BerGenBio ASA has a market cap or net worth of 24.07 million as of January 23, 2025. Its market cap has decreased by -64.50% in one year.
Market Cap
24.07M
Enterprise Value
11.48M
Revenue
36.92K
Ranking
n/a
PE Ratio
n/a
Stock Price
8.50
Market Cap Chart
Since April 7, 2017, BerGenBio ASA's market cap has decreased from 116.09M to 24.07M, a decrease of -79.27%. That is a compound annual growth rate of -18.27%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 171.37B |
| GSK plc | 55.43B |
| Haleon | 33.25B |
| Smith & Nephew | 9.04B |
| ConvaTec Group | 4.92B |
| Hikma Pharmaceuticals | 4.68B |
| HUTCHMED (China) | 1.94B |
| Oxford Nanopore Technologies | 1.48B |